Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 31 out of 100. Vascular contributions

Topic: Brain proteins, microglia and lab models

Our research, conducted both in vivo and ex vivo, demonstrated a 50% decrease in pressure-induced constriction in the CADASIL ACT zone. Membrane potential recordings indicated that CADASIL ACT zone pericytes were notably more hyperpolarized (-51 mV) than control pericytes (-32 mV). Our ex vivo pressure myography and in vivo cranial window experiments revealed that the CADASIL ACT zone minimally responded to K ATP agonist pinacidil, whereas controls exhibited significant dilation (17% versus 44%). Conversely, the CADASIL ACT zone exhibited a robust constriction in response to K ATP antagonist glibenclamide, unlike controls (28% versus 10%). Further investigation into K ATP channel hyperactivity in CADASIL using intact microvascular perforated patch revealed that ACT zone pericytes had a significantly higher basal current, which was sensitive to the K ATP antagonist glibenclamide. In silico modeling using membrane potential, patch-clamp, and ex vivo pressure myography data suggested that K ATP channel hyperactivity increases blood flow in the upper cortical layers at the expense of layer IV, leading to significant hypoperfusion in that region. These results support the novel concept that CADASIL’s impact on arteriolar reactivity further extends to the capillary level and ACT zone pericytes. K ATP channel hyperactivity contributes to impaired cortical blood flow distribution across different layers, enhancing perfusion in the upper layers while reducing it in layer IV. Overall, these results add valuable contributions to our understanding of SVDs and introduce new targets that could aid in rescuing the cerebral blood flow dysregulation and devastating pathological remodeling seen in CADASIL patients. This research was funded by NHLBI: DAJ F31HL170645, FD R01HL136636, NINDS: FD RF1/R01NS129022, R01/RF1NS140137 and cureCADASIL. This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Key findings

Why it matters

In tissue and animal experiments on CADASIL, a hereditary small vessel disease, pericytes in the affected zone showed KATP channel hyperactivity that modeling suggested reduces blood flow to layer IV of the cortex. This identifies a possible mechanism and target at the capillary level, but it is early laboratory work and does not show any treatment for Alzheimer's disease.

Study details

How this study scored 31/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 31 of 100.31 of 100 points earned69 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Physiology)
Journal's citation record 2 / 4 Physiology: journal h-index 168 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Fabrice Dabertrand: h-index 21 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Colorado Anschutz: institution h-index 768 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 31 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Jeffrey, D. A., Ferris, H. R., Khakpour, N., Peters, C. H., Proenza, C., Tsoukias, N. M., et al. (2025). Pericyte K ATP Channel Hyperactivity Contributes to Layer IV Cortex Hypoperfusion in Cerebral Small Vessel Disease. Physiology. https://doi.org/10.1152/physiol.2025.40.s1.1626

Vancouver

Jeffrey DA, Ferris HR, Khakpour N, Peters CH, Proenza C, Tsoukias NM, et al. Pericyte K ATP Channel Hyperactivity Contributes to Layer IV Cortex Hypoperfusion in Cerebral Small Vessel Disease. Physiology. 2025. doi:10.1152/physiol.2025.40.s1.1626.

BibTeX

@article{jeffrey2025-f8f4ff1d,
  author  = {Jeffrey, Danielle A and Ferris, Hannah R and Khakpour, Niloufar and Peters, Colin H. and Proenza, Catherine and Tsoukias, Nikolaos M. and Dabertrand, Fabrice},
  title   = {{Pericyte K ATP Channel Hyperactivity Contributes to Layer IV Cortex Hypoperfusion in Cerebral Small Vessel Disease}},
  journal = {Physiology},
  year    = {2025},
  doi     = {10.1152/physiol.2025.40.s1.1626},
  url     = {https://doi.org/10.1152/physiol.2025.40.s1.1626}
}

Related studies in Vascular contributions

Also tagged “cerebral”

900 studies in the library carry the topic tag “cerebral”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.

Similar studies

More on Vascular contributions

See all studies in Vascular contributions →